Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2026 Earnings

4AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.76

-0.56

-0.35

-0.15

Details

Expected EPS

-0.758855

Actual EPS

-0.36

Surprise EPS

0.4

Surprise Percent

+52.56%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.36 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.